Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 06-1999 | 12-1998 | 06-1998 | 12-1997 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 217,000 | 262,222 | 240,000 | 213,927 | 215,000 |
| Marketable Securities | 1,749,000 | N/A | 1,645,000 | N/A | 1,447,000 |
| Inventories | 1,537,000 | 1,403,105 | 1,154,000 | 947,589 | 855,000 |
| Other current assets | 2,490,000 | 4,394,317 | 2,389,000 | 3,581,527 | 2,206,000 |
| TOTAL | $6,080,000 | $6,059,645 | $5,509,000 | $4,743,044 | $4,802,000 |
| Non-Current Assets | |||||
| PPE Net | 3,720,000 | 3,742,882 | 3,633,000 | 3,527,551 | 3,583,000 |
| Intangibles | 144,000 | 157,105 | 106,000 | 117,969 | N/A |
| Other Non-Current Assets | 483,000 | 67,077 | 98,000 | 110,952 | 52,000 |
| TOTAL | $4,347,000 | $3,967,065 | $3,837,000 | $3,756,471 | $3,635,000 |
| Total Assets | $10,427,000 | $10,026,710 | $9,346,000 | $8,499,515 | $8,437,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,250,000 | 1,963,498 | 1,317,000 | 1,256,455 | 1,181,000 |
| Accounts payable and accrued liabilities | 367,000 | 299,248 | 293,000 | 1,154,500 | 299,000 |
| Other current liabilities | N/A | 2,277,772 | N/A | 1,119,595 | N/A |
| TOTAL | $5,263,000 | $4,540,518 | $4,145,000 | $3,530,549 | $3,886,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,260,000 | 1,620,250 | 1,804,000 | 1,794,242 | 1,841,000 |
| Other Non-Current Liabilities | 660,000 | 612,507 | 563,000 | 691,740 | 773,000 |
| TOTAL | $1,971,000 | $2,286,775 | $2,433,000 | $2,663,925 | $2,661,000 |
| Total Liabilities | $7,234,000 | $6,827,292 | $6,578,000 | $6,194,475 | $6,547,000 |
| Shareholders' Equity | |||||
| Common Shares | 910,000 | 909,727 | 906,000 | N/A | 894,000 |
| Retained earnings | N/A | 387,311 | N/A | 394,809 | N/A |
| Other shareholders' equity | 983,000 | 1,848,364 | 647,000 | 1,852,237 | 144,000 |
| TOTAL | $3,142,000 | $3,145,401 | $2,702,000 | $2,247,046 | $1,843,000 |
| Total Liabilities And Equity | $10,376,000 | $9,972,693 | $9,280,000 | $8,441,520 | $8,390,000 |